| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Are we making progress in diagnosing and preventing gastrointestinal cancers?
|
Haringsma, Jelle
|
|
2010
|
|
4 |
p. 213-220
|
artikel
|
| 2 |
Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies
|
Castells, Antoni
|
|
2015
|
|
4 |
p. 221-233
|
artikel
|
| 3 |
Chronic constipation: new diagnostic and treatment approaches
|
Lacy, Brian E.
|
|
2012
|
|
4 |
p. 233-247
|
artikel
|
| 4 |
Chronic opioid induced constipation in patients with nonmalignant pain: challenges and opportunities
|
Nelson, Alfred D.
|
|
2015
|
|
4 |
p. 206-220
|
artikel
|
| 5 |
Colonic smooth muscle cells and colonic motility patterns as a target for irritable bowel syndrome therapy: mechanisms of action of otilonium bromide
|
Rychter, Jakub
|
|
2014
|
|
4 |
p. 156-166
|
artikel
|
| 6 |
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
|
Lichtenstein, Gary R.
|
|
2013
|
|
4 |
p. 269-293
|
artikel
|
| 7 |
Conservative management of esophageal perforation due to external air-blast injury: a case report and literature review
|
Zhao, Guang-ju
|
|
2015
|
|
4 |
p. 234-238
|
artikel
|
| 8 |
Corrigendum
|
|
|
2009
|
|
4 |
p. 253-253
|
artikel
|
| 9 |
Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France
|
Kabeshova, Anastasiia
|
|
2016
|
|
4 |
p. 473-482
|
artikel
|
| 10 |
Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis
|
Sofia, M. Anthony
|
|
2016
|
|
4 |
p. 548-559
|
artikel
|
| 11 |
Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation
|
van Beurden, Yvette H.
|
|
2017
|
|
4 |
p. 373-381
|
artikel
|
| 12 |
Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma
|
Ford, Hugo
|
|
2015
|
|
4 |
p. 189-205
|
artikel
|
| 13 |
Elobixibat and its potential role in chronic idiopathic constipation
|
Acosta, Andres
|
|
2014
|
|
4 |
p. 167-175
|
artikel
|
| 14 |
Endoscopic closure of gastrocutaneous fistula with an AMPLATZERTM septal occluder device
|
Odemis, Bulent
|
|
2015
|
|
4 |
p. 239-242
|
artikel
|
| 15 |
Endoscopic closure of persistent gastrocutaneous fistulae, after percutaneous endoscopic gastrostomy (PEG) tube placement, using the over-the-scope-clip system
|
Singhal, Shashideep
|
|
2015
|
|
4 |
p. 182-188
|
artikel
|
| 16 |
Endoscopic management of iatrogenic perforations during endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for colorectal polyps: a case series
|
Pissas, Dimitrios
|
|
2015
|
|
4 |
p. 176-181
|
artikel
|
| 17 |
Endoscopic ultrasound-assisted gastrointestinal hemostasis: an evolving technique
|
Jain, Deepanshu
|
|
2016
|
|
4 |
p. 635-647
|
artikel
|
| 18 |
Epigenetic therapy in gastrointestinal cancer: the right combination
|
Abdelfatah, Eihab
|
|
2016
|
|
4 |
p. 560-579
|
artikel
|
| 19 |
Evaluation of regional and whole gut motility using the wireless motility capsule: relevance in clinical practice
|
Tran, Khoa
|
|
2012
|
|
4 |
p. 249-260
|
artikel
|
| 20 |
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?
|
Barrett, Jacqueline S.
|
|
2012
|
|
4 |
p. 261-268
|
artikel
|
| 21 |
Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal
|
Vallet-Pichard, Anais
|
|
2014
|
|
4 |
p. 148-155
|
artikel
|
| 22 |
Ipilimumab-induced colitis: experience from a tertiary referral center
|
O’Connor, Anthony
|
|
2016
|
|
4 |
p. 457-462
|
artikel
|
| 23 |
Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron
|
Lucak, Susan
|
|
2012
|
|
4 |
p. 215-218
|
artikel
|
| 24 |
LINX® Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux
|
Bonavina, Luigi
|
|
2013
|
|
4 |
p. 261-268
|
artikel
|
| 25 |
Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry
|
Shi, Hai Yun
|
|
2016
|
|
4 |
p. 449-456
|
artikel
|
| 26 |
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn’s disease
|
Ardizzone, Sandro
|
|
2016
|
|
4 |
p. 527-532
|
artikel
|
| 27 |
Neoadjuvant therapy for pancreatic cancer: an ongoing debate
|
Russo, Suzanne
|
|
2016
|
|
4 |
p. 429-436
|
artikel
|
| 28 |
Novel perspectives on therapeutic modulation of the gut microbiota
|
McCarville, Justin L.
|
|
2016
|
|
4 |
p. 580-593
|
artikel
|
| 29 |
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease
|
Williams, Chadwick
|
|
2011
|
|
4 |
p. 237-248
|
artikel
|
| 30 |
Overutilization of proton-pump inhibitors: what the clinician needs to know
|
Heidelbaugh, Joel J.
|
|
2012
|
|
4 |
p. 219-232
|
artikel
|
| 31 |
Pancreatic cancer: why is it so hard to treat?
|
Oberstein, Paul E.
|
|
2013
|
|
4 |
p. 321-337
|
artikel
|
| 32 |
PillCam COLON capsule endoscopy: recent advances and new insights
|
Adler, Samuel N.
|
|
2011
|
|
4 |
p. 265-268
|
artikel
|
| 33 |
Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease
|
Kopylov, Uri
|
|
2016
|
|
4 |
p. 513-526
|
artikel
|
| 34 |
Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer
|
Minaga, Kosuke
|
|
2016
|
|
4 |
p. 483-494
|
artikel
|
| 35 |
Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease
|
Briskey, David
|
|
2016
|
|
4 |
p. 463-472
|
artikel
|
| 36 |
Prophylaxis of hepatitis B infection in solid organ transplant recipients
|
John, Savio
|
|
2013
|
|
4 |
p. 309-319
|
artikel
|
| 37 |
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
|
Eckard, Carly
|
|
2013
|
|
4 |
p. 249-259
|
artikel
|
| 38 |
Proton-pump inhibitors for the treatment of functional dyspepsia
|
Suzuki, Hidekazu
|
|
2011
|
|
4 |
p. 219-226
|
artikel
|
| 39 |
Review: Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?
|
Simrén, Magnus
|
|
2009
|
|
4 |
p. s5-s8
|
artikel
|
| 40 |
Review: Anti-adhesion molecule therapy for inflammatory bowel disease
|
Ghosh, Subrata
|
|
2010
|
|
4 |
p. 239-258
|
artikel
|
| 41 |
Review: Diagnosis and management of Barrett’s esophagus for the endoscopist
|
Garud, Sagar S.
|
|
2010
|
|
4 |
p. 227-238
|
artikel
|
| 42 |
Review: Do patients with functional gastrointestinal disorders have an altered gut flora?
|
Quigley, Eamonn M.M.
|
|
2009
|
|
4 |
p. s23-s30
|
artikel
|
| 43 |
Review: Do probiotics improve symptoms in patients with irritable bowel syndrome?
|
Whorwell, Peter J.
|
|
2009
|
|
4 |
p. s37-s44
|
artikel
|
| 44 |
Review: Effect of probiotics on gastrointestinal function: evidence from animal models
|
Verdú, Elena F.
|
|
2009
|
|
4 |
p. s31-s35
|
artikel
|
| 45 |
Review: Hepatocellular carcinoma: the place of new medical therapies
|
Peck-Radosavljevic, Markus
|
|
2010
|
|
4 |
p. 259-267
|
artikel
|
| 46 |
Review: Predicting response to anti-TNF agents for the treatment of Crohn's disease
|
Siegel, Corey A.
|
|
2009
|
|
4 |
p. 245-251
|
artikel
|
| 47 |
Review: Tailoring the treatment to the individual in Crohn's disease
|
Louis, Edouard
|
|
2009
|
|
4 |
p. 239-244
|
artikel
|
| 48 |
Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs
|
Pawlotsky, Jean-Michel
|
|
2009
|
|
4 |
p. 205-219
|
artikel
|
| 49 |
Review: The treatment of irritable bowel syndrome
|
Lacy, Brian E.
|
|
2009
|
|
4 |
p. 221-238
|
artikel
|
| 50 |
Review: Tools for the tract: understanding the functionality of the gastrointestinal tract
|
Kovatcheva-Datchary, Petia
|
|
2009
|
|
4 |
p. s9-s22
|
artikel
|
| 51 |
Rifaximin for the treatment of acute infectious diarrhea
|
Hong, Kyoung Sup
|
|
2011
|
|
4 |
p. 227-235
|
artikel
|
| 52 |
Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial
|
Basu, P. Patrick
|
|
2010
|
|
4 |
p. 221-225
|
artikel
|
| 53 |
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ
|
Guinane, Caitriona M.
|
|
2013
|
|
4 |
p. 295-308
|
artikel
|
| 54 |
Specialized enteral nutrition therapy in Crohn’s disease patients on maintenance infliximab therapy: a meta-analysis
|
Nguyen, Douglas L.
|
|
2015
|
|
4 |
p. 168-175
|
artikel
|
| 55 |
Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls
|
Duran, Natalie E.
|
|
2016
|
|
4 |
p. 533-547
|
artikel
|
| 56 |
Successful transgastric pancreaticography and endoscopic ultrasound-guided drainage of a disconnected pancreatic tail syndrome
|
Will, Uwe
|
|
2011
|
|
4 |
p. 213-218
|
artikel
|
| 57 |
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection
|
Puig, Ignasi
|
|
2016
|
|
4 |
p. 437-448
|
artikel
|
| 58 |
The association between socioeconomic status and the symptoms at diagnosis of celiac disease: a retrospective cohort study
|
Roy, Abhik
|
|
2016
|
|
4 |
p. 495-502
|
artikel
|
| 59 |
The challenge of developing new therapies for irritable bowel syndrome
|
Azpiroz, Fernando
|
|
2009
|
|
4 |
p. 201-203
|
artikel
|
| 60 |
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes
|
Fiorino, Gionata
|
|
2016
|
|
4 |
p. 503-512
|
artikel
|
| 61 |
The interplay between the microbiome and the adaptive immune response in cancer development
|
Russo, Edda
|
|
2016
|
|
4 |
p. 594-605
|
artikel
|
| 62 |
The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions
|
Vindigni, Stephen M.
|
|
2016
|
|
4 |
p. 606-625
|
artikel
|
| 63 |
The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis
|
Van Wagner, Lisa B.
|
|
2011
|
|
4 |
p. 249-263
|
artikel
|
| 64 |
Traction using a clip-with-line is a preferred method for trainees in performing esophageal endoscopic submucosal dissection: an animal model study
|
Jin, Peng
|
|
2017
|
|
4 |
p. 343-351
|
artikel
|
| 65 |
Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance
|
Ammendola, Michele
|
|
2017
|
|
4 |
p. 353-360
|
artikel
|
| 66 |
Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis
|
Zar-Kessler, Claire
|
|
2016
|
|
4 |
p. 626-634
|
artikel
|
| 67 |
Universal molecular screening does not effectively detect Lynch syndrome in clinical practice
|
Brennan, Beatrice
|
|
2017
|
|
4 |
p. 361-371
|
artikel
|
Tijdschrift beschrijving